Blueprint Medicines Corporation Claimed Company
Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to?rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy. read more
Michael Landsittel — Chief Financial Officer at Blueprint Medicines Corporation
Executive Bio
Michael Landsittel serves as the Chief Financial Officer of Blueprint Medicines Corporation. Michael Landsittel and the Blueprint Medicines Corporation executive team are rated an A+ by 80 employees.
Executive Team Culture Ratings from Blueprint Medicines Corporation Employees
TOP
5%
Blueprint Medicines Corporation's Executive Team scores in the Top 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
Blueprint Medicines Corporation's Executive Team at a Glance
Based on 160 ratings, Blueprint Medicines Corporation's employees are very satisfied with their Executive Team and give them an “A+” or 90/100. On average, Women provided higher ratings for their Executive Team compared to Men. Also, the COO department thinks more highly of the Executive Team relative to the Sales department.
Blueprint Medicines Corporation's Executive Team ranks in the Top 5% of other companies in Boston and Top 5% of other companies on Comparably that also have 501-1,000 Employees.
×